Get the Stockscreener App
0.5348
0.96%
-0.0052
After Hours:
.53
-0.0048
-0.90%
Century Therapeutics Inc stock is traded at $0.5348, with a volume of 1.16M.
It is down -0.96% in the last 24 hours and down -4.26% over the past month.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
See More
Previous Close:
$0.54
Open:
$0.5328
24h Volume:
1.16M
Relative Volume:
1.33
Market Cap:
$46.20M
Revenue:
$2.24M
Net Income/Loss:
$-136.67M
P/E Ratio:
-0.2335
EPS:
-2.29
Net Cash Flow:
$-102.08M
1W Performance:
-8.28%
1M Performance:
-4.26%
6M Performance:
+2.49%
1Y Performance:
-63.37%
1-Day Range:
$0.505
$0.535
1-Week Range:
$0.505
$0.65
52-Week Range:
$0.3418
$1.83
Century Therapeutics Inc Stock (IPSC) Company Profile
Name
Century Therapeutics Inc
Sector
Industry
Phone
215-981-4000
Address
25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA
Compare IPSC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IPSC
Century Therapeutics Inc
|
0.5348 | 46.65M | 2.24M | -136.67M | -102.08M | -2.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Century Therapeutics Inc Stock (IPSC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-08-24 | Initiated | Rodman & Renshaw | Buy |
| Aug-28-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-27-22 | Initiated | Chardan Capital Markets | Buy |
| Oct-31-22 | Initiated | Guggenheim | Buy |
| Oct-10-22 | Initiated | Canaccord Genuity | Buy |
| May-23-22 | Initiated | H.C. Wainwright | Buy |
| May-12-22 | Initiated | William Blair | Mkt Perform |
| Jul-13-21 | Initiated | BofA Securities | Buy |
| Jul-13-21 | Initiated | JP Morgan | Overweight |
| Jul-13-21 | Initiated | Piper Sandler | Overweight |
View All
Century Therapeutics Inc Stock (IPSC) Latest News
What machine learning models say about Century Therapeutics Inc.Day Trade & Free Verified High Yield Trade Plans - newser.com
What does recent volatility data suggest for Century Therapeutics Inc.Trade Risk Assessment & Consistent Growth Equity Picks - newser.com
Analyzing drawdowns of Century Therapeutics Inc. with statistical toolsWeekly Stock Recap & Weekly High Momentum Picks - newser.com
Real time pattern detection on Century Therapeutics Inc. stockJuly 2025 Sentiment & Free Risk Controlled Daily Trade Plans - newser.com
What technical signals suggest for Century Therapeutics Inc. stock2025 Breakouts & Breakdowns & Technical Pattern Recognition Alerts - newser.com
Century Therapeutics Inc. stock trend outlook and recovery pathMarket Performance Recap & Risk Controlled Stock Alerts - newser.com
Century Therapeutics Inc. stock trendline breakdownWeekly Trade Summary & Consistent Profit Focused Trading Strategies - newser.com
What Fibonacci levels say about Century Therapeutics Inc. reboundWeekly Loss Report & Daily Chart Pattern Signal Reports - newser.com
Visual analytics tools that track Century Therapeutics Inc. performanceJobs Report & Fast Entry Momentum Trade Alerts - newser.com
Published on: 2025-11-06 01:22:48 - newser.com
How Century Therapeutics Inc. stock performs in rising dollar environmentJuly 2025 Summary & Daily Technical Forecast Reports - newser.com
Is Century Therapeutics Inc. stock a safe haven asset2025 Geopolitical Influence & Verified Trade Idea Suggestions - fcp.pa.gov.br
Can volume confirm reversal in Century Therapeutics Inc.2025 EndofYear Setup & Trade Opportunity Analysis - newser.com
Century Therapeutics Inc. stock volume spike explained2025 Historical Comparison & Stepwise Trade Signal Implementation - newser.com
It is Poised to be a Bull Market for Century Therapeutics Inc (IPSC) - setenews.com
Century Therapeutics Inc. stock momentum explained2025 Pullback Review & Free Growth Oriented Trading Recommendations - newser.com
Custom strategy builders for tracking Century Therapeutics Inc.Market Weekly Review & Weekly Stock Performance Updates - newser.com
Published on: 2025-11-03 01:13:25 - newser.com
How to manage a losing position in Century Therapeutics Inc.Quarterly Growth Report & AI Driven Stock Reports - newser.com
How Century Therapeutics Inc. stock compares to industry benchmarksPortfolio Return Summary & Short-Term Trading Alerts - newser.com
What Macro Risks Could Undermine Mach Conferences and Events Limiteds ForecastCurrency Fluctuation Impact & Small Investment Growth Plans - earlytimes.in
Does Century Therapeutics Inc. show high probability of reboundEarnings Recap Report & Weekly Watchlist for Consistent Profits - newser.com
Century Therapeutics Inc Stock (IPSC) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.44%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):